Frontiers in oncology.

In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...Our Cancer Center managed to continue oncology services throughout the COVID pandemic, whereas other Centers may have redeployed staff that precluded this. It is also a strength of our study that we used clearly defined definitions of COVID-19 severity, as well as a DAG to develop the different models, as to date very limited knowledge is …Frontier internet service ventures off the beaten path to provide internet in rural areas. With popular features and various speed options, you can likely find a plan that fits you...» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416

Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression. The Gastrointestinal Cancers: Colorectal Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. Even though the molecular machinery triggering and sustaining colorectal carcinogenesis and the morphogenetic pathways leading ...

Chengli Wang. Liling Lin. Jiayao Wu. Ganglan Fu. Zhongqi Liu. Minghui Cao. Frontiers in Oncology. doi 10.3389/fonc.2024.1345766. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.

Introduction. Indeed, publications concerning radiomic technique for oncology keep increasing over the past decade. In their valuable article, Ding et al. conducted a bibliometric analysis on the field of radiomics in oncology, with the aim of informing beginners and encouraging more researchers to participate in practicing …See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes. Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners. The special issue will focus on the application of new methods, viewpoints and technologies for the diagnosis and treatment of brain tumors including brain ...

Navionics charts

Introduction. Non-communicable Diseases (NCD) were responsible for 15 million premature deaths (30-69 years) worldwide in 2016, with more than 85% of these deaths occurring in low- and middle …

Research Topics. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.Scope. This section aims to publish significant clinical and basic research findings on all aspects related to hematologic malignancies, including the areas of acute and chronic leukemias, lymphomas and Hodgkin’s disease, plasma cell disorders, and stem cell transplantation. Our ultimate goal is to accelerate the communication in the field ...Scope. The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, …Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.weixing dai. Shanghai Cancer Center, Fudan University. Shanghai, China. Associate Editor. Gastrointestinal Cancers: Colorectal Cancer. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of colorectal neoplasia.Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ...

We conducted a rapid bibliometric evaluation of TDM in oncology to capture a snapshot of research in this area over time and explore topics that reflect development in the field. Reports with the composite, indexed term ‘therapeutic drug monitoring’ in the title and abstract were extracted from MEDLINE (inception to August 2021).natarajan bhaskaran. Sri Ramachandra Institute of Higher Education and Research. Chennai, India. Associate Editor. Pharmacology of Anti-Cancer Drugs. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment.Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ...James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.Apr 2, 2023 ... The AACR's Annual Meeting 2023 will be the crossroads of the cancer research world April 14-19, bringing together thousands of experts from ...Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ...liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.

May 10, 2024 · Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology. sharon r pine. Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus. Aurora, United States. Assistant Field Chief Editor. Frontiers in Oncology.

Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite.Chengli Wang. Liling Lin. Jiayao Wu. Ganglan Fu. Zhongqi Liu. Minghui Cao. Frontiers in Oncology. doi 10.3389/fonc.2024.1345766. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Dec 21, 2023 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). 1 Introduction. The human epidermal growth factor receptor protein tyrosine kinase family, including EGFR and HER2, has emerged as an important therapeutic target for non-small cell lung cancer, breast cancer, and gastroesophageal cancer (1, 2).In NSCLC, EGFR exon 20 insertions mutations account for 1.5-2.5% of all NSCLC, 6% of …Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...

Photomath online

3 days ago · See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.

1 Introduction. RMS is the most common soft tissue sarcoma in children, accounting for about half of all soft tissue tumors, which are usually localized in the extremities, trunk, head, and neck (1, 2).It is rarely observed in adults and only accounts for 3% of adult soft tissue sarcomas, which has a significantly worse prognosis compared to …Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or …Scope. This section of Frontiers in Oncology aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities. We welcome contributions from the basic and translational neurosciences, in addition to research derived from clinical studies and …List of posts by tag Frontiers in OncologyBreast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Our Cancer Center managed to continue oncology services throughout the COVID pandemic, whereas other Centers may have redeployed staff that precluded this. It is also a strength of our study that we used clearly defined definitions of COVID-19 severity, as well as a DAG to develop the different models, as to date very limited knowledge is …Pediatric Oncology. sergi aranda. National Center for Genomic Analysis, Center for Genomic Regulation (CRG) Barcelona, Spain. Associate Editor. Pediatric Oncology. nicoleta arva. Feinberg School of Medicine, Northwestern University. …harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era. Telemedicine has historically been underutilized in medicine broadly, and specifically in oncology, despite the general availability of the needed infrastructure to offer it as a platform for remote care. The COVID-19 pandemic posed new risks of infection …

Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... 1 Introduction. RMS is the most common soft tissue sarcoma in children, accounting for about half of all soft tissue tumors, which are usually localized in the extremities, trunk, head, and neck (1, 2).It is rarely observed in adults and only accounts for 3% of adult soft tissue sarcomas, which has a significantly worse prognosis compared to …Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections.Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...Instagram:https://instagram. italian wine Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health … hd home run Survival of 48866 cancer patients: results from Nantong area, China. Objective: This study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China. Methods: Patients with cancer registered between 2007 and 2017 in the Nantong rural … retro bowl game The immunogenicity of cancer cells is a new determinant of anti-cancer immunotherapy. In addition to the development of dendritic cell-based vaccines, immune checkpoint inhibitors and adoptive T cell transfer, researchers have begun to pay more attention on the immunobiology of dead cancer cells and their correlation with the success of cancer ... india mother india They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.If you’re in the market for a reliable and versatile off-road vehicle, then look no further than the Nissan Frontier 4×4. With its rugged design, powerful performance, and advanced... how to recover messages on android 32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India. flip game 6,872 views. 5 articles. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. phillips collection museum Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).Scope. This section aims to publish significant clinical and basic research findings on all aspects related to hematologic malignancies, including the areas of acute and chronic leukemias, lymphomas and Hodgkin’s disease, plasma cell disorders, and stem cell transplantation. Our ultimate goal is to accelerate the communication in the field ... meme stickers Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ... beautiful backgrounds Jan 23, 2024 · 3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ... Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ... battlegrounds game They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field. jw player Our Cancer Center managed to continue oncology services throughout the COVID pandemic, whereas other Centers may have redeployed staff that precluded this. It is also a strength of our study that we used clearly defined definitions of COVID-19 severity, as well as a DAG to develop the different models, as to date very limited knowledge is …Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225